| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4030802 | Ophthalmology | 2006 | 5 Pages |
Abstract
Patients undergoing intravitreal injection of TA with no vitreous reflux have a risk of short-term elevation of IOP that rapidly normalizes over 30 minutes. In patients with vitreous reflux after the injection, the IOP declines immediately after injection and rapidly normalizes over 10 minutes.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Matthew S. MD, Thomas A. MD, Eric R. MD, Rohit R. MD, Andrew C. MD, Mohan N. MD, Petros E. BMBCh,